InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by ROBERTS EIRY, Directeur Médical. Officer active across 2 companies, notably Amicus Therapeutics, INC.. In total, 7 disclosures have been published. Total volume traded: €574k. The latest transaction was filed on 9 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
012,671 shares0
Common Stock
SEC:0001209191-22-035847:0·
€114,4341,623 shares@ €70.50770.0008% mcap19.9% of flow
Common Stock
SEC:0001209191-22-008216:0·
€114,4341,623 shares@ €70.50770.0008% mcap39.9% of flow
Common Stock
SEC:0001209191-22-008216·
€172,7042,632 shares@ €65.61710.0012% mcap60.1% of flow
Common Stock
SEC:0001209191-22-003104·
€172,7042,632 shares@ €65.61710.0012% mcap30.1% of flow
Common Stock
SEC:0001209191-22-003104:0·
022,759 shares0
Common Stock
SEC:0001209191-21-040374·
022,759 shares0
Common Stock
SEC:0001209191-21-040374:0·
7 of 7 declarations
About ROBERTS EIRY
Eiry Roberts is the Chief Medical Officer at AMICUS THERAPEUTICS, INC. and NEUROCRINE BIOSCIENCES INC. He is responsible for leading the medical and clinical initiatives of these companies. His expertise in the life sciences field is essential for developing innovative treatments.
